| scholarly article | Q13442814 |
| P2093 | author name string | H Wessells | |
| N Levine | |||
| M E Hadley | |||
| R Dorr | |||
| V Hruby | |||
| ME Hadley | |||
| P433 | issue | S4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | S74-9 | |
| S74-S79 | |||
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | International Journal of Impotence Research | Q15749221 |
| P1476 | title | Melanocortin receptor agonists, penile erection and sexual motivation: human studies with Melanotan II | |
| Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II | |||
| P478 | volume | 12 | |
| 12 Suppl 4 |
| Q24535020 | A role for the melanocortin 4 receptor in sexual function |
| Q28366045 | Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO |
| Q26741767 | Advances in the treatment of erectile dysfunction: what's new and upcoming? |
| Q31008739 | Agonist-Dependent Internalization of the Human Melanocortin-4 Receptors in Human Embryonic Kidney 293 Cells |
| Q73293522 | Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTII |
| Q38917039 | Design of cyclic peptides with biological activities from biologically active peptides: the case of peptide modulators of melanocortin receptors |
| Q42160961 | Diagnosis and treatment of erectile dysfunction--a practical update. |
| Q36865785 | Discrete melanocortin-sensitive neuroanatomical pathway linking the ventral premmamillary nucleus to the paraventricular hypothalamus |
| Q30252468 | Drugs in preclinical to phase II clinical development for the treatment of erectile dysfunction |
| Q36052249 | Effects of leptin and melanocortin signaling interactions on pubertal development and reproduction |
| Q37933090 | Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction |
| Q38367700 | Emerging drugs for the treatment of erectile dysfunction |
| Q35765882 | Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition |
| Q101564372 | Genetics and erectile dysfunction: leveraging early foundations for new discoveries |
| Q90366981 | Hindbrain melanocortin 3/4 receptors modulate the food intake and body weight suppressive effects of the GLP-1 receptor agonist, liraglutide |
| Q87766471 | Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet |
| Q103017461 | LC-HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of PIEDs |
| Q28256494 | Melanocortin Receptor Agonists Facilitate Oxytocin-Dependent Partner Preference Formation in the Prairie Vole |
| Q34432482 | Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: results from basic research and clinical studies |
| Q92741440 | Melanotan II: a possible cause of renal infarction: review of the literature and case report |
| Q33585575 | Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies |
| Q90581717 | Novel Emerging Therapies for Erectile Dysfunction |
| Q35544237 | Novel agents for sexual dysfunction |
| Q44485757 | Novel tetrahydropyran-based peptidomimetics from a bioisosteric transformation of a tripeptide. Evidence of their activity at melanocortin receptors |
| Q36377258 | Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo |
| Q34583191 | Organic chemistry and biology: chemical biology through the eyes of collaboration |
| Q80298043 | Pharmacologic treatment of erectile dysfunction |
| Q38583391 | Pharmacotherapeutic management of erectile dysfunction |
| Q33650796 | Research in pharmacotherapy for erectile dysfunction |
| Q50069050 | Sim1 Neurons Are Sufficient for MC4R-Mediated Sexual Function in Male Mice |
| Q47120733 | Synthesis and Structure-Activity Relationships of Substituted Urea Derivatives on Mouse Melanocortin Receptors |
| Q73252173 | Synthesis of 2,4,5-Trisubstituted Tetrahydropyrans as Peptidomimetic Scaffolds for Melanocortin Receptor Ligands |
| Q34343356 | Synthesis, biophysical, and pharmacological evaluation of the melanocortin agonist AST3-88: modifications of peptide backbone at Trp 7 position lead to a potent, selective, and stable ligand of the melanocortin 4 receptor (MC4R). |
| Q28273671 | The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases |
| Q36866594 | The future of the oral pharmacotherapy of male erectile dysfunction: things to come |
| Q34635467 | The role of melanocortins in body weight regulation: opportunities for the treatment of obesity |
| Q74604281 | The role of melanocortins in body weight regulation: opportunities for the treatment of obesity |
| Q44625615 | Therapy of erectile dysfunction in 2005 |
| Q35774919 | Therapy of erectile dysfunction: potential future treatments |
Search more.